Publication
Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine Polyplexes
dc.contributor.author | Pereira, Patrícia | |
dc.contributor.author | Barreira, Maria | |
dc.contributor.author | Cruz, Carla | |
dc.contributor.author | Tomás, Joana | |
dc.contributor.author | Luís, Ângelo | |
dc.contributor.author | Pedro, Augusto | |
dc.contributor.author | Queiroz, João | |
dc.contributor.author | Sousa, Fani | |
dc.date.accessioned | 2020-12-02T10:21:14Z | |
dc.date.available | 2020-12-02T10:21:14Z | |
dc.date.issued | 2020 | |
dc.description.abstract | The efficacy of brain therapeutics is largely hampered by the presence of the blood-brain barrier (BBB), mainly due to the failure of most (bio) pharmaceuticals to cross it. Accordingly, this study aims to develop nanocarriers for targeted delivery of recombinant precursor microRNA (pre-miR-29b), foreseeing a decrease in the expression of the BACE1 protein, with potential implications in Alzheimer's disease (AD) treatment. Stearic acid (SA) and lactoferrin (Lf) were successfully exploited as brain-targeting ligands to modify cationic polymers (chitosan (CS) or polyethyleneimine (PEI)), and its BBB penetration behavior was evaluated. The intracellular uptake of the dual-targeting drug delivery systems by neuronal cell models, as well as the gene silencing efficiency of recombinant pre-miR-29b, was analyzed in vitro. Labeled pre-miR-29b-CS/PEI-SA-Lf systems showed very strong fluorescence in the cytoplasm and nucleus of RBE4 cells, being verified the delivery of pre-miR-29b to neuronal cells after 1 h transfection. The experiment of transport across the BBB showed that CS-SA-Lf delivered 65% of recombinant pre-miR-29b in a period of 4 h, a significantly higher transport ratio than the 42% found for PEI-SA-Lf in the same time frame. Overall, a novel procedure for the dual targeting of DDS is disclosed, opening new perspectives in nanomedicines delivery, whereby a novel drug delivery system harvests the merits and properties of the different immobilized ligands. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.3390/ph13100314 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.6/10530 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.relation | CICECO-Aveiro Institute of Materials | |
dc.relation | CICECO-Aveiro Institute of Materials | |
dc.relation | Centre for Mechanical Enginnering, Materials and Processes | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Blood-brain barrier | pt_PT |
dc.subject | Chitosan | pt_PT |
dc.subject | Drug delivery system | pt_PT |
dc.subject | Lactoferrin | pt_PT |
dc.subject | Polyethyleneimine | pt_PT |
dc.subject | Recombinant miRNA | pt_PT |
dc.title | Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine Polyplexes | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | CICECO-Aveiro Institute of Materials | |
oaire.awardTitle | CICECO-Aveiro Institute of Materials | |
oaire.awardTitle | Centre for Mechanical Enginnering, Materials and Processes | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/5876/PEst-OE%2FSAU%2FUI0709%2F2014/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50011%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50011%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00285%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FBII-BBF%2F29496%2F2017/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F81914%2F2011/PT | |
oaire.citation.issue | 10 | pt_PT |
oaire.citation.startPage | 314 | pt_PT |
oaire.citation.title | Pharmaceuticals | pt_PT |
oaire.citation.volume | 13 | pt_PT |
oaire.fundingStream | 5876 | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 9471 - RIDTI | |
oaire.fundingStream | SFRH | |
person.familyName | Pereira | |
person.familyName | Cruz | |
person.familyName | Melfe Tomás | |
person.familyName | Santos Luís | |
person.familyName | Quaresma Henriques Pedro | |
person.familyName | Queiroz | |
person.familyName | Sousa | |
person.givenName | Patrícia | |
person.givenName | Carla | |
person.givenName | Joana Filipa | |
person.givenName | Ângelo Filipe | |
person.givenName | Augusto | |
person.givenName | João | |
person.givenName | Fani | |
person.identifier | https://scholar.google.com/citations?user=oer44UoAAAAJ&hl=pt-PT&oi=ao | |
person.identifier.ciencia-id | 4715-067B-4FD0 | |
person.identifier.ciencia-id | 6816-7888-F8B1 | |
person.identifier.ciencia-id | F51D-5365-D95D | |
person.identifier.ciencia-id | 3D14-798B-65D3 | |
person.identifier.ciencia-id | 7111-B2BE-336D | |
person.identifier.ciencia-id | 931E-B66D-E341 | |
person.identifier.ciencia-id | 991D-2E13-A840 | |
person.identifier.orcid | 0000-0002-5665-5271 | |
person.identifier.orcid | 0000-0001-6630-1242 | |
person.identifier.orcid | 0000-0001-8796-5152 | |
person.identifier.orcid | 0000-0003-0712-6522 | |
person.identifier.orcid | 0000-0001-8194-6022 | |
person.identifier.orcid | 0000-0002-3096-8325 | |
person.identifier.orcid | 0000-0001-9996-2194 | |
person.identifier.rid | I-7806-2013 | |
person.identifier.rid | L-3104-2014 | |
person.identifier.rid | A-2014-2017 | |
person.identifier.scopus-author-id | 56111844900 | |
person.identifier.scopus-author-id | 7202701394 | |
person.identifier.scopus-author-id | 54080426100 | |
person.identifier.scopus-author-id | 7003705645 | |
person.identifier.scopus-author-id | 7005110268 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 157c4d6b-e0e0-4ef2-9d25-e461156ced0c | |
relation.isAuthorOfPublication | 3fc51bf5-f849-4292-9aa3-4947fac1b9c8 | |
relation.isAuthorOfPublication | 48246814-0853-4ad4-af6c-171f804e68a8 | |
relation.isAuthorOfPublication | a2d7c872-99db-41e1-9bc9-82c2d47b4661 | |
relation.isAuthorOfPublication | e105301c-3c7f-4705-961d-944d6db208dd | |
relation.isAuthorOfPublication | c798c033-c160-4f99-a8ad-04416923943f | |
relation.isAuthorOfPublication | 2935de97-fc90-4d38-9505-4caa364f8a10 | |
relation.isAuthorOfPublication.latestForDiscovery | 3fc51bf5-f849-4292-9aa3-4947fac1b9c8 | |
relation.isProjectOfPublication | f6d0aa1d-d8a8-4438-b222-023db42ef45e | |
relation.isProjectOfPublication | 821b0a9f-4ed0-4706-bba0-970f1c8fd36a | |
relation.isProjectOfPublication | 41080a5c-2736-4a4e-a75d-42c4ac988ade | |
relation.isProjectOfPublication | 69fdf4ae-d7ec-46b2-87fe-7a70e4de9724 | |
relation.isProjectOfPublication | 73c33ee3-c2fc-42ab-a3eb-f9c988dbe88c | |
relation.isProjectOfPublication | f94f7921-0d41-4f42-b6cc-e94be6c382c5 | |
relation.isProjectOfPublication.latestForDiscovery | f6d0aa1d-d8a8-4438-b222-023db42ef45e |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- pharmaceuticals-13-00314.pdf
- Size:
- 3.44 MB
- Format:
- Adobe Portable Document Format